Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
P31944
UPID:
CASPE_HUMAN
Alternative names:
-
Alternative UPACC:
P31944; O95823; Q3SYC9
Background:
Caspase-14, a non-apoptotic caspase, plays a pivotal role in epidermal differentiation. It is the primary caspase in the stratum corneum, essential for keratinocyte differentiation and cornification. This enzyme processes filaggrin, a key protein in skin barrier function, and is involved in the degradation of DNA in differentiated keratinocytes by cleaving DFFA/ICAD.
Therapeutic significance:
Caspase-14's involvement in congenital ichthyosis, a disorder marked by abnormal skin scaling, underscores its therapeutic potential. Understanding the role of Caspase-14 could open doors to potential therapeutic strategies for skin disorders.